Tianjin Lisheng Pharmaceutical Co.,Ltd.

002393

CNE100000NJ9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
16.5 ^CNY	-0.60%		-0.90%	-11.49%

11/06	Lisheng Pharmaceutical Avails of 92-Day Structured Deposit Product	MT
22/05	Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 28 May 2024	CI

Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 28 May 2024

May 22, 2024

Tianjin Lisheng Pharmaceutical Co.,Ltd. announced final cash dividend /10 shares (tax included) of CNY 6.00000000 on A shares for the year 2023. Record date is 27 May 2024. Ex-date is 28 May 2024 and Payment date is 28 May 2024.

Latest news about Tianjin Lisheng Pharmaceutical Co.,Ltd.

Lisheng Pharmaceutical Avails of 92-Day Structured Deposit Product	11/06	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces Final Cash Dividend Plan on A Shares for the Year 2023, Payable on 28 May 2024	22/05	CI
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Tianjin Lisheng Pharmaceutical Co.,Ltd. Proposes Cash Dividend for the Year 2023	23/03	CI
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. acquired 65% stake in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. from Jiangxi Qingchun Kangyuan Group Co., Ltd. and Jiangxi Qingchun Kangyuan Chinese Medicine Co., Ltd.	29/02	CI
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02	CI
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01	MT
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. agreed to acquire 65% stake in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. from Jiangxi Qingchun Kangyuan Group Co., Ltd. and Jiangxi Qingchun Kangyuan Chinese Medicine Co., Ltd. for approximately CNY 140 million.	14/12	CI
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12	MT
Lisheng Pharmaceutical and Lisheng Investment Enter into the Partnership Agreement with Bozheng Capital, Tianjin Jinjia and Tianjin Handeway	11/12	CI
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/23/29	CI
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire additional 15% stake in Tianjin Pharmaceutical Group Finance Co., Ltd from Tianjin Lisheng Pharmaceutical Co.,Ltd. for CNY 87.8 million.	11/23/11	CI
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25/23/25	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02/23/02	MT
Lisheng Pharma to Receive 247.9 Million Yuan for Relocation	26/23/26	MT
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26/23/26	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 30 June 2023	21/23/21	CI
Tianjin Lisheng Pharma Gets Nod For Febuxostat Active Pharma Ingredient in China	15/23/15	MT
Lisheng Pharma Unit's Drug Passes Regulatory Evaluation	15/23/15	MT
Tianjin Lisheng Pharmaceutical's Q1 Attributable Profit Increases	27/23/27	MT
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI

Chart Tianjin Lisheng Pharmaceutical Co.,Ltd.

Duration

Period

Chart Tianjin Lisheng Pharmaceutical Co.,Ltd.

More charts

Company Profile

Tianjin Lisheng Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the manufacture and distribution of chemical drugs. The Company's major products are tablets, hard capsules, pills, free-dry powder injections, water injections and raw drugs, including drugs for cardio and cerebral vascular systems, anti-infection drugs and hormone drugs, among others. It distributes its products mainly within domestic markets.

Sector

Pharmaceuticals

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
TIANJIN LISHENG PHARMACEUTICAL CO.,LTD.	-11.49%	58Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.37%	4.35TCr
OTSUKA HOLDINGS CO., LTD.	+18.30%	2.18TCr
SANDOZ GROUP AG	+19.07%	1.54TCr
CIPLA LIMITED	+25.55%	1.51TCr
ZYDUS LIFESCIENCES LIMITED	+60.99%	1.34TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-14.84%	638.15Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+8.17%	532.14Cr